Inhibitory effect of beta-glucosyl-phenolic hydroxamic acids against urease in the presence of microfloral beta-glucosidase.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 7742785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.

  2009cited by this paper
• Urease stones

  2004cited by this paper
• Intestinal bacterial hydrolysis is indispensable to absorption of 18β‐glycyrrhetic acid after oral administration of glycyrrhizin in rats

  1994cited by this paper
• Metabolism of barbaloin by intestinal bacteria.

  1988cited by this paper
• A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients.

  1987cited by this paper
• A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis.

  1984cited by this paper
• Urease inhibitor therapy in infected renal stones.

  1981cited by this paper
• Hydroxyurea in the management of chronic urea-splitting urinary infections.

  1980cited by this paper
• Metabolism of Sennosides by Human Intestinal Bacteria

  1980cited by this paper
• The importance of the small intestine in gut ammonium production in the fasting dog.

  1979cited by this paper
• Hyperammonemic coma after hepatectomy in germ-free rats.

  1979cited by this paper
• [Inhibition of ureolysis in rat intestine with some antimicrobial agents in vivo and in vitro (author's transl)].

  1979cited by this paper
• Struvite stones.

  1978cited by this paper
• Urease. The primary cause of infection-induced urinary stones.

  1976cited by this paper
• Pathogenesis of hepatic coma.

  1975cited by this paper
• Hepatic encephalopathy: current status.

  1974cited by this paper
• Intestinal microflora.

  1971cited by this paper
• Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid.

  1968cited by this paper
• Acetohydroxamate: Bacterial Urease Inhibitor with Therapeutic Potential in Hyperammonaemic States

  1965cited by this paper
• Specific inhibition of urease by hydroxamic acids.

  1962cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Identification of novel urease inhibitors: pharmacophore modeling, virtual screening and molecular docking studies

  2019cites this paper
• In Silico study of the active site of Helicobacter pylori urease and its inhibition by hydroxamic acids.

  2018cites this paper
• 3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.

  2016cites this paper
• Chemistry and mechanism of urease inhibition.

  2002cites this paper
• Hydroxamic acids as pharmacological agents.

  2002cites this paper
• Effects of Shikunshito-Kamiho on fecal enzymes and formation of aberrant crypt foci induced by 1,2-dimethylhydrazine.

  2001cites this paper